top of page
Browse by category
Search
Neurons that control the amount of MC4R affect how much the protein guards against obesity
Mutations in a gene called OTP cause obesity by controlling the output of another gene already targeted by an anti-obesity drug, a study...
Global Commission proposes major overhaul of obesity diagnosis, going beyond BMI to define when obesity is a disease
The Lancet Commission on Clinical Obesity recommends a new, nuanced approach where measures of body fat - for example, waist...
Multi-layered omics analysis offers insight into biology and risk factors of childhood obesity
A cutting-edge molecular approach provides a detailed picture of the biological pathways associated with childhood obesity and metabolic...
Study finds persistent racial disparities and growing sex disparities of bariatric patients
There are persistent racial disparities and growing sex disparities between patients who discussed and received bariatric and metabolic...
Journal Watch 15/1/2025
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
AUDACITY Trial: Low rate of serious adverse events supports favourable safety profile of the Allurion Balloon
Allurion Technologies has revealed topline results - from the AUDACITY Food & Drug Administration (FDA) pivotal trial evaluating the...
ReShape Lifesciences provides merger update with Vyome Therapeutics
ReShape Lifesciences and Vyome Therapeutics have provided an update on the definitive merger agreement under which ReShape and Vyome will...
Over half of Americans are unaware that bariatric surgery can improve fertility
A new national survey by Orlando Health has found 56% of Americans are unaware that bariatric surgery improves fertility. Infertility...
Journal Watch 8/1/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Biomea Fusion announces first data on icovamenib-semaglutide combination study
Biomea Fusion has announced ‘compelling’ results from in vivo studies of icovamenib in combination with semaglutide. Icovamenib is an...
Browse by tag
bottom of page